{{Infobox medical intervention
| name         = Birth control
| synonyms     = Contraception, fertility control
| image        = Opened Oral Birth Control.jpg
| alt          = Package of birth control pills
| caption      = A package of [[birth control pills]]
| ICD10        =
| ICD9         =
| ICD9unlinked =
| MeshID       = D003267
| LOINC        =
| other_codes  =
| MedlinePlus  =
| eMedicine    =
}}
'''ဒစဵုဒၞာဂဗ္ဘ (Birth control)'''  ဂှ် ဒှ်နဲကဲ ဟွံသေင်မ္ဂး မစကာအရပ်အရာမွဲမွဲ သွက်စဵုဒၞာ ညံင်ဟွံတန်ဂဗ္ဘ (ဝါ) ညံင်ဟွံတန်ပဋိသန္ဓိ (ဝါ) ညံင်ဟွံဂွံဗုင်ရ။<ref>{{Cite web|title=Definition of Birth control|url=http://www.medterms.com/script/main/art.asp?articlekey=53351|work=MedicineNet|accessdate=August 9, 2012|archiveurl=https://web.archive.org/web/20120806234913/http://www.medterms.com/script/main/art.asp?articlekey=53351|archivedate=August 6, 2012}}</ref> ဒစဵုဒၞာဂဗ္ဘဂှ် ကောန်မၞိဟ်တအ် စကာကၠုင် နူကဵု အခိင်တမၠာတေအ်ရ၊ ဆဂး ဒစဵုဒၞာဂဗ္ဘ နကဵု နဲကဲမကၠောန်ကမၠောန်ခိုဟ်ဟ် ကေုာံ သက္ကုဘဲအန္တရာယ်ဂှ် စကလိဂွံ ပ္ဍဲကဵုခေတ် ၂၀ ဗွဝ်ကၠံရ။<ref name="Hopkins2010">{{Cite book|title=The Johns Hopkins manual of gynecology and obstetrics}}</ref> ပ္ဍဲကဵု အခိုက်ကၞာလ္ၚဵုဂှ်မ္ဂး ဒစဵုဒၞာဂဗ္ဘဂှ် ညးတအ်ဟွံဒုင်တဲ၊ ညးတအ် ညာတ်ကေတ် ဒှ်အရာမဗၠေတ်ကဵု ဒ္ဂေတ်ပြဝ၊ ဒစဵုဒစး ကုလညာတ်ဘာသာ ဟွံသေင်မ္ဂး လညာတ်ပရေင်ဍုင်ကွာန်ရ။

ဒစဵုဒၞာဂဗ္ဘ နဲကဲ မကၠောန်ကမၠောန်ခိုဟ်အိုတ်ဂှ် ဒှ်နဲကဲ ဇမ္အး (sterilization) မဂွံအဓိပ္ပါယ် မဗပိုတ် ကတေင်ကောန် ပ္ဍဲကဵု မၞိဟ်တြုဟ်၊ ဟွံသေင်မ္ဂး ပ္ဍဲကဵု မၞိဟ်ဗြဴ မကော်ဂး  intrauterine devices (IUDs)၊ ကေုာံ ဒစဵုဒၞာဂဗ္ဘ နမပတံစုတ် (implantable birth control) ရ။ ဒစဵုဒၞာဂဗ္ဘ နမပတံစုတ်ဂှ် ဒှ် နဲကဲ မဒုင်သဇိုင် ကုဓါတ်ဟောရ်မုန် (hormone-based methods) နွံနာနာသာ် မပတံကဵု ဂဥုဲစဵုဒၞာဲ (oral pills)၊ ပလာတ်သတာ (patches)၊ လကံက်ယောနိ (vaginal rings)၊ ကေုာံ ထပက်ဂဥုဲ (injections) ရ။ နကဵုနဲတၞဟ် မလေပ်ကၠောန်ကမၠောန် ဟွံခိုဟ်ကွေဟ်ဟ် နကဵု နဲမစဵုဒၞာ နကဵုကာယ မပတံကဵု နဲမစကာ  ကောန်ဒေါမ် (condoms) မဓလိုက်စုတ် ပ္ဍဲအင်္ဂဇာတ် မၞိဟ်တြုဟ်၊ diaphragms ကဵု birth control sponges မဒှ်ဂရောပ် မစုတ်ပၠုပ် ပ္ဍဲယောနိမၞိဟ်ဗြဴ ကေုာံ နဲမစွံသတိ ကမၠောအ်မ (fertility awareness methods) မဒှ်နဲ မဝေင်ပါဲ ပ္ဍဲတ္ၚဲ ညးဗြဴဖျေဟ်ခၟာဲ။ နကဵုနဲ မကၠောန်ကမၠောန် အောန်အိုတ်ဂှ် ဒှ်နဲ ဂမ္စိုတ်သုက် (spermicides) မဒှ်ဂဥုဲ မစုတ်ပၠုပ် ပ္ဍဲယောနိမၞိဟ်ဗြဴ ကိုပ်ကၠာ ဟွံဆက်ဆောံလိင် အခိင်ညိည၊ မပကဵု ညံင်စၟသုက်ဂွံချိုတ် ကေုာံ နဲမၞိဟ်တြုဟ်ၜေတ်ပတိတ် ကိုပ်ကၠာ ဟွံစရိုဟ် (withdrawal by the male before ejaculation) ရ။ နကဵုနဲဇမ္အးဂှ် ဒှ်နဲ ကလေင်ကေတ်ဟွံဂွံတုဲ နဲတၞဟ်တအ်ဂှ် ဒှ်နဲကလေင်ဂွံ သီုဖအိုတ်တုဲ ဒှ်နဲ မပဒေါအ်ဇူလဝ် မွဲအခိင်ကာလရ။<ref name="WHO_FP2011">{{Cite book|author=World Health Organization Department of Reproductive Health and Research|title=Family planning: A global handbook for providers: Evidence-based guidance developed through worldwide collaboration|year=2011|publisher=WHO and Center for Communication Programs|location=Geneva|isbn=978-0-9788563-7-3|url=http://www.fphandbook.org/sites/default/files/hb_english_2012.pdf|edition=Rev. and Updated}}</ref> စကာ နဲ [[လိင် မသက်ကုဘဲ|လိင်မသက်ကုဘဲ]] မပတံကဵု နဲမစကာကောန်ဒေါမ် မၞိဟ်တြုဟ် ကေုာံ ကောန်ဒေါမ်မၞိဟ်ဗြဴတအ်ဂှ် သီုဒှ် နဲမစဵုဒၞာ ညံင်ယဲဟွံဂွံကၠောအ် နကဵုမဆက်ဆောမ်လိင်ကီုရ။<ref name="pmid22423463">{{Cite journal|author=Taliaferro|title=We have the evidence to enhance adolescent sexual and reproductive health—do we have the will?|year=2011}}</ref> နဲဒစဵုဒၞာဂဗ္ဘတၞဟ်တအ်ဂှ် စဵုဒၞာကဵု ညံင်ယဲဟွံဂွံကၠောအ် နကဵုမဆက်ဆောမ်လိင် ဟွံမာန်ရ။<ref name="pmid22341164">{{Cite journal|author=Chin|title=The Effectiveness of Group-Based Comprehensive Risk-Reduction and Abstinence Education Interventions to Prevent or Reduce the Risk of Adolescent Pregnancy, Human Immunodeficiency Virus, and Sexually Transmitted Infections|year=2012|url=http://www.ajpmonline.org/article/S0749-3797(11)00906-8/abstract}}</ref> ကြဴနူ ဆက်ဆောံလိင် သက်ကုစဵုဒၞာတုဲ အပ္ဍဲ အခိင်အကြာ ၇၂ ကဵု ၁၂၀ နာဍဳဂှ် စကာ နဲဒစဵုဒၞာဂဗ္ဘ ကာမံက်တိုန် (Emergency birth control) ဂွံမာန်ရ။<ref name="Gizzo2012">{{Cite journal|author=Gizzo|title=Nowadays which emergency contraception? Comparison between past and present: latest news in terms of clinical efficacy, side effects and contraindications}}</ref><ref>{{Cite book|title=Selected practice recommendations for contraceptive use|publisher=World Health Organization|location=Geneva|isbn=978-92-4-156284-3|edition=2nd|url=https://books.google.com/books?id=77hFLypBfHYC&pg=RA2-PA16}}</ref> ညးလ္ၚဵုဂှ်ဟီု ဟွံမိက်ဂွံ ကောန်ဇာတ်မ္ဂး [[ပၞာဲ မေထုန်|လ္ပဆက်ဆောံလိင်]] ရ။ ပညာလိင် မဒုင်သဇိုင် ကုပၞာဲမေထုန် ဟေင်ဂှ် ဒှ်အရာ မဂလိုင်ကဵု လၟိဟ် သၟာဲလေင် (သၟဝ်အာယုက် ၂၀) ဗုင်တိတ်/ သၟာဲလေင်တန်ဂဗ္ဘ မာန်ရ။ မေထုန်ဂှ် ဒှ်အရာသဘာဝ သတ်တအ်တုဲ ယဝ်ရ ညးသၟတ်တအ် ဟွံဂွံတီလဝ် နဲကဲဒစဵုဒၞာဂဗ္ဘမ္ဂး ယဝ်ရပညာလိင်ဂှ် ဒုင်သဇိုင် ကုနဲပၞာဲမေထုန်သၟး (ဝါ) ယဝ်ရ ဟီုလဝ် ဝေင်ပါဲဓဝ်မေထုန်သၟး ဆၜိုတ်ဏအ်ရမ္ဂး လၟိဟ်သၟာဲလေင်တန်ဂဗ္ဘဂှ် ဂၠိုင်တိုန်မာန်ရ။ ဟွံသေင်မ္ဂး ဟိုတ်နူ တန်အာဂဗ္ဘတုဲ ပ္ဍဲကဵု အာယုက်ဍောတ်တ်ဂှ် ဒးဒက်ဘဝအိန်ထံင်ဂှ် ဂၠိုင်ကၠုင်ရ။<ref name="pmid12065267">{{Cite journal|title=Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials|url=}}</ref><ref name="pmid18923389">{{Cite journal|author=Duffy|title=Government Support for Abstinence-Only-Until-Marriage Education|year=2008|url=http://www.nature.com/clpt/journal/v84/n6/full/clpt2008188a.html}}</ref>

ပ္ဍဲဘဝသၟာဲလေင် (သၟဝ် အာယုက် ၂၀) ဂှ် ဒှ်ဟိုတ် မဖန်ဗဒှ်ကဵု ဘဝဒိုက်ဂတ်မာန်ရ။ နကဵု[[ပညာလိင်|ပညာလိင် ဗွဲမဍိုက်ပင်]] ကေုာံ မကလိဂွံ ဒစဵုဒၞာဂဗ္ဘဂှ် ဖန်ကဵု ညံင်ဂွံဖအောန်ဖျေဟ် ဒဒှ်မတန်ဂဗ္ဘ သက်ကုမနွံပၟိက် ပ္ဍဲကဵုဘဝသၟတ် မကော်ဂး ဘဝသၟာဲလေင်ဝွံမာန်ရ။<ref name="pmid22764559">{{Cite journal|author=Black|title=Pregnancy in adolescents|pages=xi, 123–38|year=2012}}</ref><ref name="pmid22764557">{{Cite journal|author=Rowan|title=Contraception for primary care providers|pages=x–xi, 95–110|year=2012}}</ref>ပ္ဍဲကဵု ဘဝသၟတ်ဂှ် နဲကဲဒစဵုဒၞာဂဗ္ဘ မကလေင်ကေတ်ဂွံ မပတံကဵု စကာကောန်ဒေါမ်၊ စုတ်လကံက်ယောနိ၊ စုတ်တၞိင်ဟောရ်မုန်တအ်ဂှ် မလေပ်စကာ ဂွံဖအိုတ်တုဲ နကဵုနဲတအ်ဏအ် ဖအောန်ကဵု လၟိဟ်မတန်ဂဝ် ပ္ဍဲဘဝသၟာဲလေင်မာန်ရ။ နဲကဲမကလေင်ကေတ်ဟွံဂွံ (ဝါ) မကလေင်ကေတ်ဝါတ် ဗီုကဵု ဗပိုတ် ကတေင်ကောန်တအ်ဂှ် သွက်ညးသၟတ်တအ် ဟွံထေက်ကဵု စကာဏီရ။ ပါဲနူဂှ်တုဲ ကုညးဗြဴ မကလိဂွံကောန်ဇာတ်တၟိတၟိ ကောန်ဍောတ်ဒၟံင်ဏီ ဟွံမဲပၟိက် တန်ပဋိသန္ဓိဏီတအ်လေဝ် စကာ နဲဒစဵုဒၞာဂဗ္ဘတအ် ဂွံကီုရ။ မၞိဟ်ဗြဴတအ်ဂှ် ကြဴနူ သၠးဂၠံဂဝ်တုဲ အကြာ ပန်သတ္တဟ ကဵု တြဴသတ္တဟဂှ် တန်ဂၠံဂဝ်မာန်ဒၟံင်ရ။ ညးလ္ၚဵုထေင်ကေတ် ယဝ်ရ ဇကုဗမဴတှ်ကဵု ကောန်ၚာ်မ္ဂး တန်ဂၠံဂဝ်ဟွံမာန်ရ။ ဟိုတ်ဂှ်ရ သၠးဂၠံဂဝ်တုဲဗက်ဂှ် ယဝ်ရဇကုဟွံမဲပၟိက် တန်ဂၠံဂဝ်ဏီမ္ဂး ဒးစကာ နဲဒစဵုဒၞာဂဗ္ဘ နကဵုနဲလ္ၚဵုတအ်ဂှ် လဝါဲဂှ်ရ။ နဲလ္ၚဵုဂှ်မ္ဂး သၠးဂၠံဂဝ်တုဲ ဒးမင် မွဲလစုတ် ၜိုတ်တြဴဂိတုတုဲမ္ဂး စကာဂွံရ။<ref name="WHO_FP2011p260">{{Cite book|author=World Health Organization Department of Reproductive Health and Research|title=Family planning: A global handbook for providers: Evidence-based guidance developed through worldwide collaboration|year=2011|pages=260–300|publisher=WHO and Center for Communication Programs|location=Geneva|isbn=978-0-9788563-7-3|url=http://www.fphandbook.org/sites/default/files/hb_english_2012.pdf|edition=Rev. and Updated}}</ref>

== နဲကဲဂမၠိုင် ==

{| class="wikitable sortable" style="float: right; margin-left:15px; text-align:center"
|+Chance of pregnancy during first year of use<ref name=Trus2011>{{cite journal|last=Trussell|first=James|date=May 2011|title=Contraceptive failure in the United States|journal=Contraception|volume=83|issue=5|pages=397–404|doi=10.1016/j.contraception.2011.01.021|pmc=3638209|pmid=21477680}}<br />{{cite book|last=Trussell|first=James|year=2011|chapter=Contraceptive efficacy|editor1-last=Hatcher|editor1-first=Robert A.|editor2-last=Trussell|editor2-first=James|editor3-last=Nelson|editor3-first=Anita L.|editor4-last=Cates|editor4-first=Willard Jr.|editor5-last=Kowal|editor5-first=Deborah|editor6-last=Policar|editor6-first=Michael S. |title=Contraceptive technology|edition=20th revised|location=New York|publisher=Ardent Media|pages=779–863|isbn=978-1-59708-004-0|issn=0091-9721|oclc=781956734}}</ref><ref name=CDC2013>{{cite journal|authors=Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC)|date=June 21, 2013|title=U.S. Selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization Selected practice recommendations for contraceptive use, 2nd edition|journal=MMWR Recommendations and Reports|volume=62|issue=5|pages=1–60|pmid=23784109|url=https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm|url-status=live|archiveurl=https://web.archive.org/web/20130710101031/http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm|archivedate=July 10, 2013|df=mdy-all}}</ref>
! Method !! Typical use !! Perfect use
|-
| No birth control || 85% || 85%
|-
| Combination pill || 9% || 0.3%
|-
| Progestin-only pill || 13% || 1.1%
|-
| Sterilization (female) || 0.5% || 0.5%
|-
| Sterilization (male) || 0.15% || 0.1%
|-
| Condom (female) || 21%|| 5%
|-
| Condom (male) || 18% || 2%
|-
| Copper IUD || 0.8% || 0.6%
|-
| Hormonal IUD || 0.2% || 0.2%
|-
| Patch || 9% || 0.3%
|-
| Vaginal ring || 9% || 0.3%
|-
| [[Medroxyprogesterone acetate|MPA]] shot || 6% || 0.2%
|-
| Implant || 0.05% || 0.05%
|-
| Diaphragm and spermicide || 12% || 6%
|-
| Fertility awareness || 24% || 0.4–5%
|-
| Withdrawal || 22% || 4%
|-
| Lactational amenorrhea method<br /> (6 months failure rate) || 0–7.5%<ref name= Vanderwijden>{{cite journal|last1=Van der Wijden|first1=C|last2=Manion|first2=C|title=Lactational amenorrhoea method for family planning|journal=The Cochrane Database of Systematic Reviews|date=12 October 2015|issue=10|pages=CD001329|pmid=26457821|pmc=6823189|doi=10.1002/14651858.CD001329.pub2}}</ref> || <2%<ref name=Blenning2005 />
|}

နဲကဲဒစဵုဒၞာဂဗ္ဘဂှ် နွံဒၟံင် သီုဖအိုတ် မသုန်နဲဂှ် နဲဒၞာခြာ (barrier methods)၊ နဲဂဥုဲဟောရ်မုန် (hormonal birth control)၊ နဲမဂြောပ်စုတ် (intrauterine devices) (IUDs)၊ နဲဇမ္အး (sterilization)၊ ကေုာံ နဲပၞာဲ (behavioral methods) တအ်ရ။ နဲလ္ၚဵုဂှ် စကာ ကိုပ်ကၠာ ဟွံသိပ်ဂၠိပ်မေထုန်၊ နဲလ္ၚဵုဂှ် စကာ အဃောမသိပ်ဂၠိပ်မေထုန်တုဲ နဲစဵုဒၞာကာတၟေင် (emergency contraceptive) ဂှ် ကြဴနူ သိပ်ဂၠိပ်မေထုန်တုဲ စဵုကဵုမသုန်တ္ၚဲ မြဴသာ်ဝွံ ဗီုမစကာ နဲကဲတအ်ဂှ် ဟွံတုပ် ရေင်သကအ်အိုတ်ရ။ နဲလ္ၚဵုဂှ် ဖန်လဝ် မွဲအလန်တုဲ ဍေဟ်ကၠောန်ကမၠောန် လလအ် ပွိုင်မွဲသၞာံ၊<ref>{{cite book|author=Gordon Edlin|author2=Eric Golanty|author3=Kelli McCormack Brown|title=Essentials for health and wellness|year=2000|publisher=Jones and Bartlett|location=Sudbury, MA|isbn=978-0-7637-0909-9|page=161|url=https://books.google.com/books?id=_0H4iyS_DFwC&pg=PA162|edition=2nd|url-status=live|archiveurl=https://web.archive.org/web/20160610000602/https://books.google.com/books?id=_0H4iyS_DFwC&pg=PA162|archivedate=June 10, 2016|df=mdy-all}}</ref> နဲလ္ၚဵု ဗီုကဵု နဲဗပိုတ် ကတေင်ကောန်တအ်ဂှ် ဍေဟ်ကၠောန်ကမၠောန် လလအ်ဇမၠိင်အာယုက်ရ။<ref name=Dew2012>{{cite book|editor-last=Edmonds|editor-first=D. Keith|title=Dewhurst's textbook of obstetrics & gynaecology|publisher=Wiley-Blackwell|year=2012|location=Chichester, West Sussex|isbn=978-0-470-65457-6|page=508|url=https://books.google.com/books?id=HfakBRceodcC&pg=PA508|edition=8th|url-status=live|archiveurl=https://web.archive.org/web/20160503061741/https://books.google.com/books?id=HfakBRceodcC&pg=PA508|archivedate=May 3, 2016|df=mdy-all}}</ref>

နဲမကၠောန်ကမၠောန်ဂၠိုင်အိုတ် နဲဗပိုတ်သ္ၚိကောန်ဂှ် ဖန်လဝ် မွဲအလန်တုဲ ဟွံဒးအာ စဳစတ် ကုအစာဂဥုဲရ။<ref name=Will2012 /> နဲဂဥုဲဟောရ်မုန် မပတံကဵု ထပက်စုတ် ဂဥုဲ ပ္ဍဲကာယ၊ ပၠုပ်စုတ် ကိရိယာပ္ဍဲယောနိတအ်ဂှ် ဂွံပွိုင်မွဲသၞာံတုဲမ္ဂး ဒြဟတ်စဵုဒၞာ (ဝါ) ဒြဟတ်ကၠောန်ကမၠောန်ဍေဟ် အောန်စှ်ေအာ ၁% ရ။<ref name=Trus2011 /> ပလာသတာ လကံက်ယောနိ၊ ကေုာံ နဲ lactational amenorrhea method (LAM) တအ်လေဝ် ပေင်မွဲသၞာံတုဲမ္ဂး ဒြဟတ်စဵုဒၞာ အောန်စှ်ေအာ ၁% ကီုရ။<ref name=Will2012 />

နဲကဲဒစဵုဒၞာဂဗ္ဘတအ်ဂှ် နိသံသဍေဟ် ပကဵု အရာတၞဟ်တအ်မာန် နွံညိညကီုလေဝ် အန္တရာယ်ဟွံဇၞော် နူတန်ပဋိသန္ဓိ ပ္ဍဲဘဝသၟတ်ရ။<ref name=Will2012>{{cite book|last1=Cunningham|first1=F. Gary|last2=Stuart|first2=Gretchen S.|year=2012|chapter=Contraception and sterilization|editor1-last=Hoffman|editor1-first=Barbara|editor2-last=Schorge|editor2-first=John O.|editor3-last=Schaffer|editor3-first=Joseph I.|editor4-last=Halvorson|editor4-first=Lisa M.|editor5-last=Bradshaw|editor5-first=Karen D.|editor6-last=Cunningham|editor6-first=F. Gary|title=Williams gynecology|edition=2nd|location=New York|publisher=McGraw-Hill Medical|pages=132–69|isbn=978-0-07-171672-7}}</ref> ကြဴနူ မပဒေါအ် ဟွံသေင်မ္ဂး ပတိတ်ထောအ် ကိရိယာဒစဵုဒၞာဂဗ္ဘတအ်တုဲ အခေါင်မတန်ဂဗ္ဘမာန် အပ္ဍဲပွိုင်မွဲသၞာံဂှ် တုပ်သၟဟ်ကဵု မၞိဟ်ဟွံကေင် စကာလဝ် ကိရိယာတအ်ရ။ <ref>{{cite journal|last=Mansour|first=D|last2=Gemzell-Danielsson |first2=K |last3=Inki |first3=P |last4=Jensen |first4=JT|title=Fertility after discontinuation of contraception: a comprehensive review of the literature|journal=Contraception|date=November 2011|volume=84|issue=5|pages=465–77|pmid=22018120|doi=10.1016/j.contraception.2011.04.002|ref=harv}}</ref>

ညးဗြဴလ္ၚဵု ဟိုတ်နူစကာ နဲကဲဒစဵုဒၞာဂဗ္ဘတုဲ ဗဒှ်ကဵု ပြသၞာ ပရေင်ထတ်ယုက်နွံကီုလေဝ် ကုညးပရေင်ထတ်ယုက်ခိုဟ်တအ်ဂှ် ဟိုတ်နူ ဒစဵုဒၞာဂဗ္ဘတုဲ ဗဒှ်ကဵု ပြသၞာပရေင်ထတ်ယုက်ဂှ် အောန်ကွေဟ်ရ။<ref>{{cite book|last=Department of Reproductive Health and Research, Family and Community|title=Selected practice recommendations for contraceptive use.|year=2004|publisher=World Health Organization|location=Geneva|isbn=978-92-4-156284-3|page=Chapter 31|url=http://whqlibdoc.who.int/publications/2004/9241562846.pdf|edition=2nd|url-status=live|archiveurl=https://web.archive.org/web/20130718091826/http://whqlibdoc.who.int/publications/2004/9241562846.pdf|archivedate=July 18, 2013|df=mdy-all}}</ref> ပ္ဍဲသၞာံ ၂၀၀၉ ဂှ် နကဵု ဂကောံပရေင်ထတ်ယုက်ဂၠးကဝ် (WHO) ပ္တိတ်လဝ် နိသံသမကတဵုဒှ်မာန် ဇၟာပ်ပ် နဲကဲဒစဵုဒၞာဂဗ္ဘရ။ ဟိုတ်ဂှ်ရ ကိုပ်ကၠာ ဇကုဟွံရုဲစှ် နဲကဲလဵုမကိတ်ညဳကဵုဇကုဂှ် ချပ်ဂၞန် ကုသဝ်ဝန် စမ်ဆီတုဲ ရုဲစှ်မ္ဂး ခိုဟ်အိုတ်ရ။<ref name=WHO2009_10>{{cite book|last=Organization|first=World Health|title=Medical eligibility criteria for contraceptive use|year=2009|publisher=Reproductive Health and Research, World Health Organization|location=Geneva|isbn=978-92-4-156388-8|pages=1–10|url=http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf|edition=4th|url-status=live|archiveurl=https://web.archive.org/web/20120709230021/http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf|archivedate=July 9, 2012|df=mdy-all}}</ref>

=== ဂဥုဲဟောရ်မုန် (Hormonal) ===

နဲကဲ ဂဥုဲဟောရ်မုန်ဏအ်ဂှ် နွံဗီုပြင်နာနာသာ် မပတံကဵု ဂဥုဲသွုင် (oral pills) (လ္ၚဵုကော် ဂဥုဲကာဒ်)၊ တၞုင် ဒစဵုဒၞာဂဗ္ဘ (contraceptive implant) မထ္ပက်စုတ် ပ္ဍဲစၞာံ၊ ဂဥုဲတၞုင် (injectable contraceptives)၊ ပလာသတာ ဒစဵုဒၞာဂဗ္ဘ (contraceptive patch) မဗာန်လဝ် ပ္ဍဲဇကု၊ ပါ်ဟောရ်မုန် (hormonal IUD) မစုတ်ပၠုပ် ပ္ဍဲယောနိ ကေုာံ လကံက်ယောနိ (vaginal ring) လကံက်မပၠုပ်စုတ်လဝ် ပ္ဍဲယောနိမၞိဟ်ဗြဴရ။ <ref>{{cite news|last=Mackenzie|first=James|title=The male pill? Bring it on|url=https://www.theguardian.com/commentisfree/2013/dec/06/male-contraceptive-pill-bring-it-on|accessdate=May 20, 2014|newspaper=The Guardian|date=December 6, 2013|url-status=live|archiveurl=https://web.archive.org/web/20140521031817/http://www.theguardian.com/commentisfree/2013/dec/06/male-contraceptive-pill-bring-it-on|archivedate=May 21, 2014|df=mdy-all}}</ref> There are two types of oral birth control pills, the [[combined oral contraceptive pill]]s (which contain both [[estrogen (medication)|estrogen]] and a [[progestin]]) and the [[progestogen-only pill]]s (sometimes called minipills).<ref name="Ammer 2009a">{{cite book|last=Ammer|first=Christine|year=2009|chapter=oral contraceptive|title=The encyclopedia of women's health|edition=6th|location=New York|publisher=Facts On File|isbn=978-0-8160-7407-5|pages=312–15|chapterurl=https://books.google.com/books?id=_MRDimrELCIC&pg=PA312&vq=oral+contraceptive}}</ref>  If either is taken during pregnancy, they do not increase the risk of [[miscarriage]] nor cause [[birth defects]].<ref name=WHO_FP2011p10 /> Both types of birth control pills prevent [[Human fertilization|fertilization]] mainly by inhibiting [[ovulation]] and thickening cervical mucus.<ref name="Nelson 2011">{{cite book|last1=Nelson|first1=Anita L.|last2=Cwiak|first2=Carrie|year=2011|chapter=Combined oral contraceptives (COCs)|editor1-last=Hatcher|editor1-first=Robert A.|editor2-last=Trussell|editor2-first=James|editor3-last=Nelson|editor3-first=Anita L.|editor4-last=Cates|editor4-first=Willard Jr.|editor5-last=Kowal|editor5-first=Deborah|editor6-last=Policar|editor6-first=Michael S. |title=Contraceptive technology|edition=20th revised|location=New York|publisher=Ardent Media|pages=249–341 [257–58]|isbn=978-1-59708-004-0|issn=0091-9721|oclc=781956734}}</ref><ref name=Williams2011>{{cite book|author1=Barbara L. Hoffman|title=Williams gynecology|date=2011|publisher=McGraw-Hill Medical|location=New York|isbn=978-0-07-171672-7|edition=2nd|chapter=5 Second-Tier Contraceptive Methods—Very Effective}}</ref> They may also change the lining of the uterus and thus decrease implantation.<ref name=Williams2011 /> Their effectiveness depends on the user's adherence to taking the pills.<ref name="WHO_FP2011p10" />

<!--Combined  -->
Combined hormonal contraceptives are associated with a slightly increased risk of [[venous thrombosis|venous]] and [[arterial thrombosis|arterial blood clots]].<ref name=Review2011 /> Venous clots, on average, increase from 2.8 to 9.8 per 10,000 women years<ref>{{cite journal|last=Stegeman|first=BH|last2=de Bastos |first2=M |last3=Rosendaal |first3=FR |last4=van Hylckama Vlieg |first4=A |last5=Helmerhorst |first5=FM |last6=Stijnen |first6=T |last7=Dekkers |first7=OM|title=Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis|journal=BMJ (Clinical Research Ed.)|date=Sep 12, 2013|volume=347|pages=f5298|pmid=24030561|doi=10.1136/bmj.f5298|pmc=3771677}}</ref> which is still less than that associated with pregnancy.<ref name=Review2011>{{cite journal|last=Brito|first=MB|last2=Nobre |first2=F |last3=Vieira |first3=CS|title=Hormonal contraception and cardiovascular system|journal=Arquivos Brasileiros de Cardiologia|date=April 2011|volume=96|issue=4|pages=e81–89|pmid=21359483|doi=10.1590/S0066-782X2011005000022|ref=harv|doi-access=free}}</ref> Due to this risk, they are not recommended in women over 35&nbsp;years of age who continue to smoke.<ref>{{cite journal|last1=Kurver|first1=Miranda J.|last2=van der Wijden|first2=Carla L.|last3=Burgers|first3=Jako|date=October 4, 2012|title=Samenvatting van de NHG-standaard 'Anticonceptie' [Summary of the Dutch College of General Practitioners' practice guideline 'Contraception']|journal=Nederlands Tijdschrift voor Geneeskunde|volume=156|issue=41|page=A5083|pmid=23062257|language=Dutch|url=http://www.ntvg.nl/publicatie/samenvatting-van-de-nhg-standaard-‘anticonceptie’}}</ref> Due to the increased risk, they are included in decision tools such as the [[DASH score]] and [[PERC rule]] used to predict the risk of blood clots.<ref>{{cite journal|last1=Tosetto|first1=A|display-authors=etal|title=Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)|journal=J Thromb Haemost|date=2012|volume=10|issue=6|pages=1019–25|doi=10.1111/j.1538-7836.2012.04735.x|pmid=22489957}}</ref>

The effect on sexual desire is varied, with increase or decrease in some but with no effect in most.<ref>{{cite journal|last=Burrows|first=LJ|author2=Basha, M |author3=Goldstein, AT |title=The effects of hormonal contraceptives on female sexuality: a review|journal=The Journal of Sexual Medicine|date=September 2012|volume=9|issue=9|pages=2213–23|pmid=22788250|doi=10.1111/j.1743-6109.2012.02848.x}}</ref> Combined oral contraceptives reduce the risk of [[ovarian cancer]] and [[endometrial cancer]] and do not change the risk of [[breast cancer]].<ref name=Shulman2011 /><ref>{{cite journal|last=Havrilesky|first=LJ|last2=Moorman |first2=PG |last3=Lowery |first3=WJ |last4=Gierisch |first4=JM |last5=Coeytaux |first5=RR |last6=Urrutia |first6=RP |last7=Dinan |first7=M |last8=McBroom |first8=AJ |last9=Hasselblad |first9=V |last10=Sanders |first10=GD |last11=Myers |first11=ER|title=Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis|journal=Obstetrics and Gynecology|date=July 2013|volume=122|issue=1|pages=139–47|pmid=23743450|doi=10.1097/AOG.0b013e318291c235}}</ref> They often reduce menstrual bleeding and [[dysmenorrhea|painful menstruation cramps]].<ref name=WHO_FP2011p10>{{cite book|author=World Health Organization Department of Reproductive Health and Research|title=Family planning: A global handbook for providers: Evidence-based guidance developed through worldwide collaboration|year=2011|pages=1–10|publisher=WHO and Center for Communication Programs|location=Geneva|isbn=978-0-9788563-7-3|url=http://www.fphandbook.org/sites/default/files/hb_english_2012.pdf|edition=Rev. and Updated|url-status=live|archiveurl=https://web.archive.org/web/20130921054335/http://www.fphandbook.org/sites/default/files/hb_english_2012.pdf|archivedate=September 21, 2013|df=mdy-all}}</ref> The lower doses of estrogen released from the vaginal ring may reduce the risk of breast tenderness, [[nausea]], and headache associated with higher dose estrogen products.<ref name=Shulman2011>{{cite journal|last=Shulman|first=LP|title=The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives|journal=American Journal of Obstetrics and Gynecology|date=October 2011|volume=205|issue=4 Suppl|pages=S9–13|pmid=21961825|doi=10.1016/j.ajog.2011.06.057}}</ref>

<!--Progestin  -->
Progestin-only pills, injections and intrauterine devices are not associated with an increased risk of blood clots and may be used by women with a history of blood clots in their veins.<ref name=Review2011 /><ref>{{cite journal|last=Mantha|first=S.|last2=Karp |first2=R. |last3=Raghavan |first3=V. |last4=Terrin |first4=N. |last5=Bauer |first5=K.A. |last6=Zwicker |first6=J.I.|title=Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis|journal=BMJ|date=August 7, 2012|volume=345|issue=aug07 2|pages=e4944|doi=10.1136/bmj.e4944|ref=harv|pmid=22872710|pmc=3413580}}</ref> In those with a history of arterial blood clots, non-hormonal birth control or a progestin-only method other than the injectable version should be used.<ref name=Review2011 /> Progestin-only pills may improve menstrual symptoms and can be used by breastfeeding women as they do not affect [[lactation|milk production]]. Irregular bleeding may occur with progestin-only methods, with some users reporting [[amenorrhea|no periods]].<ref name="pmid21961819">{{cite journal|last=Burke|first=AE|title=The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives|journal=American Journal of Obstetrics and Gynecology|date=October 2011|volume=205|issue=4 Suppl|pages=S14–7|pmid=21961819|doi=10.1016/j.ajog.2011.04.033}}</ref> The progestins [[drospirenone]] and [[desogestrel]] minimize the [[androgen]]ic side effects but increase the risks of blood clots and are thus not first line.<ref>{{cite journal|last=Rott|first=H|title=Thrombotic risks of oral contraceptives.|journal=Current Opinion in Obstetrics and Gynecology|date=August 2012|volume=24|issue=4|pages=235–40|pmid=22729096|doi=10.1097/GCO.0b013e328355871d}}</ref> The perfect use first-year failure rate of [[Medroxyprogesterone acetate|injectable progestin]] is 0.2%; the typical use first failure rate is 6%.<ref name=Trus2011 />

<gallery class="center" align="center">
File:Plaquettes de pilule.jpg|alt=birth control pill packages|Three varieties of [[Combined oral contraceptive pill|birth control pills]] in calendar oriented packaging
File:Birth Control Pills.png|Birth control pills
File:BirthControlPatch.JPG|alt=a contraceptive patch|A transdermal [[contraceptive patch]]
File:NuvaRing in hand.jpg|alt=a vaginal ring|A [[NuvaRing]] vaginal ring
</gallery>

=== Barrier ===

[[Barrier contraceptive]]s are devices that attempt to prevent [[pregnancy]] by physically preventing [[sperm]] from entering the [[uterus]].<ref name=Neinstein2008 /> They include male [[condom]]s, [[female condom]]s, [[cervical cap]]s, [[Diaphragm (contraceptive)|diaphragms]], and [[contraceptive sponge]]s with [[spermicide]].<ref name=Neinstein2008>{{cite book|last=Neinstein|first=Lawrence|title=Adolescent health care : a practical guide|year=2008|publisher=Lippincott Williams & Wilkins|location=Philadelphia|isbn=978-0-7817-9256-1|page=624|url=https://books.google.com/books?id=XIzo5uo3XIQC&pg=PA624|edition=5th|url-status=live|archiveurl=https://web.archive.org/web/20160617091640/https://books.google.com/books?id=XIzo5uo3XIQC&pg=PA624|archivedate=June 17, 2016|df=mdy-all}}</ref>

Globally, condoms are the most common method of birth control.<ref>{{cite book|last=Chaudhuri|title=Practice Of Fertility Control: A Comprehensive Manual|year=2007|publisher=Elsevier India|isbn=978-81-312-1150-2|page=88|url=https://books.google.com/books?id=pzanxKlcU74C&pg=PA88|edition=7th|url-status=live|archiveurl=https://web.archive.org/web/20160430204739/https://books.google.com/books?id=pzanxKlcU74C&pg=PA88|archivedate=April 30, 2016|df=mdy-all}}</ref> [[Male condoms]] are put on a man's erect [[human penis|penis]] and physically block ejaculated sperm from entering the body of a sexual partner.<ref name=Hamil2012 /> Modern condoms are most often made from [[latex]], but some are made from other materials such as [[polyurethane]], or lamb's intestine.<ref name=Hamil2012>{{cite book|last=Hamilton|first=Richard|title=Pharmacology for nursing care|publisher=Elsevier/Saunders|location=St. Louis, MO|isbn=978-1-4377-3582-6|page=799|year=2012|url=https://books.google.com/books?id=_4SwO2dHcAIC&pg=PA799|edition=8th|url-status=live|archiveurl=https://web.archive.org/web/20160603075248/https://books.google.com/books?id=_4SwO2dHcAIC&pg=PA799|archivedate=June 3, 2016|df=mdy-all}}</ref> [[Female condom]]s are also available, most often made of [[Nitrile rubber|nitrile]], latex or polyurethane.<ref>{{cite book|title=Facts for life|year=2010|publisher=United Nations Children's Fund|location=New York|isbn=978-92-806-4466-1|page=141|url=https://books.google.com/books?id=GAFgWda-2NMC&pg=PA141|edition=4th|url-status=live|archiveurl=https://web.archive.org/web/20160513045129/https://books.google.com/books?id=GAFgWda-2NMC&pg=PA141|archivedate=May 13, 2016|df=mdy-all}}</ref> Male condoms have the advantage of being inexpensive, easy to use, and have few adverse effects.<ref>{{cite book|last=Pray|first=Walter Steven|title=Nonprescription product therapeutics|year=2005|publisher=Lippincott Williams & Wilkins|location=Philadelphia|isbn=978-0-7817-3498-1|page=414|url=https://books.google.com/books?id=XU1sMK1djVAC&pg=PA414|edition=2nd|url-status=live|archiveurl=https://web.archive.org/web/20160430062155/https://books.google.com/books?id=XU1sMK1djVAC&pg=PA414|archivedate=April 30, 2016|df=mdy-all}}</ref> Making condoms available to teenagers does not appear to affect the age of onset of sexual activity or its frequency.<ref>{{cite journal|title=Condom Use by Adolescents|journal=Pediatrics|date=October 28, 2013|volume=132|issue=5|pages=973–81|doi=10.1542/peds.2013-2821|pmid=28448257|author1=COMMITTEE ON ADOLESCENCE|doi-access=free}}</ref> In Japan, about 80% of couples who are using birth control use condoms, while in Germany this number is about 25%,<ref name=Ebe2010>{{cite book|last=Eberhard|first=Nieschlag|title=Andrology Male Reproductive Health and Dysfunction|year=2010|publisher=Springer-Verlag Berlin Heidelberg|location=[S.l.]|isbn=978-3-540-78355-8|page=563|url=https://books.google.com/books?id=mEgckDNkonUC&pg=PA563|edition=3rd|url-status=live|archiveurl=https://web.archive.org/web/20160510175547/https://books.google.com/books?id=mEgckDNkonUC&pg=PA563|archivedate=May 10, 2016|df=mdy-all}}</ref> and in the United States it is 18%.<ref>{{cite book|last=Barbieri|first=Jerome F.|title=Yen and Jaffe's reproductive endocrinology : physiology, pathophysiology, and clinical management|year=2009|publisher=Saunders/Elsevier|location=Philadelphia|isbn=978-1-4160-4907-4|page=873|url=https://books.google.com/books?id=NudwnhxY8kYC&pg=PA873|edition=6th|url-status=live|archiveurl=https://web.archive.org/web/20160518002841/https://books.google.com/books?id=NudwnhxY8kYC&pg=PA873|archivedate=May 18, 2016|df=mdy-all}}</ref>

Male condoms and the diaphragm with spermicide have typical use first-year failure rates of 18% and 12%, respectively.<ref name=Trus2011 /> With perfect use condoms are more effective with a 2% first-year failure rate versus a 6% first-year rate with the diaphragm.<ref name=Trus2011 /> Condoms have the additional benefit of helping to prevent the spread of some sexually transmitted infections such as [[HIV/AIDS]], however, condoms made from animal intestine do not.<ref name=WHO_FP2011 /><ref>{{Cite web|url=https://www.healthlinkbc.ca/healthlinkbc-files/preventing-sti|title=Preventing Sexually Transmitted Infections (STIs)|last=|first=|date=February 2017|website=British Columbia Health Link|access-date=31 March 2018}}</ref>

Contraceptive sponges combine a barrier with a spermicide.<ref name=Will2012 /> Like diaphragms, they are inserted vaginally before intercourse and must be placed over the [[cervix]] to be effective.<ref name=Will2012 /> Typical failure rates during the first year depend on whether or not a woman has previously given birth, being 24% in those who have and 12% in those who have not.<ref name=Trus2011 /> The sponge can be inserted up to 24&nbsp;hours before intercourse and must be left in place for at least six hours afterward.<ref name=Will2012 /> Allergic reactions<ref>{{cite journal|last=Kuyoh|first=MA|author2=Toroitich-Ruto, C |author3=Grimes, DA |author4=Schulz, KF |author5= Gallo, MF |title=Sponge versus diaphragm for contraception: a Cochrane review.|journal=Contraception|date=January 2003|volume=67|issue=1|pages=15–18|pmid=12521652 |doi=10.1016/s0010-7824(02)00434-1}}</ref> and more severe adverse effects such as [[toxic shock syndrome]] have been reported.<ref>{{cite book|last=Organization|first=World Health|title=Medical eligibility criteria for contraceptive use|year=2009|publisher=Reproductive Health and Research, World Health Organization|location=Geneva|isbn=978-92-4-156388-8|page=88|url=https://books.google.com/books?id=pouTfH33wF8C&pg=PA88|edition=4th|url-status=live|archiveurl=https://web.archive.org/web/20160515194650/https://books.google.com/books?id=pouTfH33wF8C&pg=PA88|archivedate=May 15, 2016|df=mdy-all}}</ref>

<gallery class="center" align="center">
File:Kondom.jpg|A rolled up male [[condom]].
File:Condom unrolled durex.jpg|alt=an unrolled condom|An unrolled male [[latex]] [[condom]]
File:Préservatif féminin.jpg|alt=a female condom|A polyurethane [[female condom]]
File:Contraceptive diaphragm.jpg|alt=a diaphragm|A [[Diaphragm (contraceptive)|diaphragm]] vaginal-cervical [[Barrier contraception|barrier]], in its case with a [[Quarter (United States coin)|quarter U.S. coin]].
File:Éponge spermicide.jpg|alt=a contraceptive sponge|A [[contraceptive sponge]] set inside its open package.
</gallery>

=== Intrauterine devices ===

[[File:Tête de stérilet.jpg|thumb|Copper T shaped IUD with removal strings]]

The current [[intrauterine device]]s (IUD) are small devices, often 'T'-shaped, containing either copper or [[levonorgestrel]], which are inserted into the uterus. They are one form of [[long-acting reversible contraception]] which are the most effective types of reversible birth control.<ref>{{Cite journal |author1=Winner, B |author2=Peipert, JF |author3=Zhao, Q |author4=Buckel, C |author5=Madden, T |author6=Allsworth, JE |author7=Secura, GM. |year=2012 |title=Effectiveness of Long-Acting Reversible Contraception |journal=New England Journal of Medicine |volume=366 |issue=21 |pages=1998–2007 |doi=10.1056/NEJMoa1110855 |pmid=22621627 |df=mdy-all |url=https://digitalcommons.wustl.edu/open_access_pubs/2773 }}</ref> Failure rates with the [[Copper IUDs|copper IUD]] is about 0.8% while the [[Levonorgestrel intrauterine system|levonorgestrel IUD]] has a failure rates of 0.2% in the first year of use.<ref name=Hopkins2010b>{{cite book|editor-last=Hurt|editor-first=K. Joseph|title=The Johns Hopkins manual of gynecology and obstetrics|publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins|location=Philadelphia|isbn=978-1-60547-433-5|page=232|url=https://books.google.com/books?id=4Sg5sXyiBvkC&pg=PR232|edition=4th|others=Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore Maryland|date=March 28, 2012|display-editors=etal|url-status=live|archiveurl=https://web.archive.org/web/20160512081611/https://books.google.com/books?id=4Sg5sXyiBvkC&pg=PR232|archivedate=May 12, 2016|df=mdy-all}}</ref> Among types of birth control, they, along with birth control implants, result in the greatest satisfaction among users.<ref name=Comm2012>{{cite journal|author=Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists|title=Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices|journal=Obstetrics and Gynecology|date=October 2012|volume=120|issue=4|pages=983–88|pmid=22996129|doi=10.1097/AOG.0b013e3182723b7d}}</ref> As of 2007, IUDs are the most widely used form of reversible contraception, with more than 180&nbsp;million users worldwide.<ref name=Darney2010>{{cite book|last=Darney|first=Leon Speroff, Philip D.|title=A clinical guide for contraception|year=2010|publisher=Lippincott Williams & Wilkins|location=Philadelphia|isbn=978-1-60831-610-6|pages=242–43|url=https://books.google.com/books?id=f5XJtYkiJ0YC&pg=PT425|edition=5th|url-status=live|archiveurl=https://web.archive.org/web/20160506220517/https://books.google.com/books?id=f5XJtYkiJ0YC&pg=PT425|archivedate=May 6, 2016|df=mdy-all}}</ref>

Evidence supports effectiveness and safety in adolescents<ref name=Comm2012 /> and those who have and have not previously had children.<ref>{{cite journal|last=Black|first=K|last2=Lotke |first2=P |last3=Buhling |first3=KJ |last4=Zite |first4=NB |last5=Intrauterine contraception for Nulliparous women: Translating Research into Action (INTRA), group|title=A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women|journal=The European Journal of Contraception & Reproductive Health Care|date=October 2012|volume=17|issue=5|pages=340–50|pmid=22834648|doi=10.3109/13625187.2012.700744 |pmc=4950459}}</ref> IUDs do not affect [[breastfeeding]] and can be inserted immediately after delivery.<ref name=Gabbe2012>{{cite book|last=Gabbe|first=Steven|title=Obstetrics: Normal and Problem Pregnancies|year=2012|publisher=Elsevier Health Sciences|isbn=978-1-4557-3395-8|page=527|url=https://books.google.com/books?id=x3mJpT2PkEUC&pg=PA527|url-status=live|archiveurl=https://web.archive.org/web/20160515213803/https://books.google.com/books?id=x3mJpT2PkEUC&pg=PA527|archivedate=May 15, 2016|df=mdy-all}}</ref> They may also be used immediately after an [[abortion]].<ref>{{cite journal|last=Steenland|first=MW|author2=Tepper, NK |author3=Curtis, KM |author4= Kapp, N |title=Intrauterine contraceptive insertion postabortion: a systematic review|journal=Contraception|date=November 2011|volume=84|issue=5|pages=447–64|pmid=22018119|doi=10.1016/j.contraception.2011.03.007|url=https://zenodo.org/record/1258857}}</ref><ref>{{Cite journal|last=Roe|first=Andrea Hsu|last2=Bartz|first2=Deborah|date=2019-01-01|title=Society of Family Planning clinical recommendations: contraception after surgical abortion|url=https://www.contraceptionjournal.org/article/S0010-7824(18)30425-6/abstract|journal=Contraception|language=English|volume=99|issue=1|pages=2–9|doi=10.1016/j.contraception.2018.08.016|issn=0010-7824|pmid=30195718}}</ref> Once removed, even after long term use, fertility returns to normal immediately.<ref>{{cite book|editor=Tommaso Falcone|editor2=William W. Hurd|title=Clinical reproductive medicine and surgery|year=2007|publisher=Mosby|location=Philadelphia|isbn=978-0-323-03309-1|page=409|url=https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA409|url-status=live|archiveurl=https://web.archive.org/web/20160617031849/https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA409|archivedate=June 17, 2016|df=mdy-all}}</ref>

While copper IUDs may increase menstrual bleeding and result in more painful cramps,<ref name=Grimes2007>{{Cite journal | author = Grimes, D.A. | title="Intrauterine Devices (IUDs)" In:Hatcher, RA; Nelson, TJ; Guest, F; Kowal, D | journal = Contraceptive Technology | edition = 19th |year = 2007 }}</ref> hormonal IUDs may reduce menstrual bleeding or stop menstruation altogether.<ref name=Gabbe2012 /> Cramping can be treated with painkillers like [[NSAIDs|non-steroidal anti-inflammatory drugs]].<ref name=Marnach2013 /> Other potential complications include expulsion (2–5%) and rarely perforation of the uterus (less than 0.7%).<ref name=Gabbe2012 /><ref name=Marnach2013>{{cite journal|last=Marnach|first=ML|author2=Long, ME |author3=Casey, PM |title=Current issues in contraception|journal=Mayo Clinic Proceedings|date=March 2013|volume=88|issue=3|pages=295–99|pmid=23489454|doi=10.1016/j.mayocp.2013.01.007|doi-access=free}}</ref> A previous model of the intrauterine device (the [[Dalkon shield]]) was associated with an increased risk of [[pelvic inflammatory disease]], however the risk is not affected with current models in those without [[sexually transmitted infections]] around the time of insertion.<ref name="guttmacher2007">{{cite web|url=http://www.guttmacher.org/pubs/gpr/10/4/gpr100419.html|title=Popularity Disparity: Attitudes About the IUD in Europe and the United States|publisher=Guttmacher Policy Review|date=2007|accessdate=April 27, 2010|url-status=live|archiveurl=https://web.archive.org/web/20100307124351/http://www.guttmacher.org/pubs/gpr/10/4/gpr100419.html|archivedate=March 7, 2010|df=mdy-all}}</ref> IUDs appear to decrease the risk of [[ovarian cancer]].<ref>{{cite journal |last1=Cramer |first1=DW |title=The epidemiology of endometrial and ovarian cancer|journal=Hematology/Oncology Clinics of North America |date=February 2012 |volume=26 |issue=1 |pages=1–12 |doi=10.1016/j.hoc.2011.10.009 |pmid=22244658|pmc=3259524 }}</ref>

=== Sterilization ===

[[Sterilisation (medicine)|Surgical sterilization]] is available in the form of [[tubal ligation]] for women and [[vasectomy]] for men.<ref name=Hopkins2010 /> There are no significant long term side effects, and tubal ligation decreases the risk of [[ovarian cancer]].<ref name=Hopkins2010 /> Short term complications are twenty times less likely from a vasectomy than a tubal ligation.<ref name=Hopkins2010 /><ref>{{cite journal |vauthors=Adams CE, Wald M |title=Risks and complications of vasectomy |journal=Urol. Clin. North Am. |volume=36 |issue=3 |pages=331–36 |date=August 2009 |pmid=19643235 |doi=10.1016/j.ucl.2009.05.009 |url=}}</ref> After a vasectomy, there may be swelling and pain of the scrotum which usually resolves in one or two weeks.<ref>{{cite book |author=Hillard, Paula Adams |title=The 5-minute obstetrics and gynecology consult |publisher=Lippincott Williams & Wilkins |location=Hagerstwon, MD |year=2008 |page=265 |isbn=978-0-7817-6942-6 |url=https://books.google.com/books?id=fOoFIQOdIhkC&pg=PA265 |url-status=live |archiveurl=https://web.archive.org/web/20160611045006/https://books.google.com/books?id=fOoFIQOdIhkC&pg=PA265 |archivedate=June 11, 2016 |df=mdy-all }}</ref> With tubal ligation, complications occur in 1 to 2 percent of procedures with serious complications usually due to the [[anesthesia]].<ref>{{cite book |author=Hillard, Paula Adams |title=The 5-minute obstetrics and gynecology consult |publisher=Lippincott Williams & Wilkins |location=Hagerstwon, MD |year=2008 |page=549 |isbn=978-0-7817-6942-6 |url=https://books.google.com/books?id=fOoFIQOdIhkC&pg=PA549 |url-status=live |archiveurl=https://web.archive.org/web/20160505132817/https://books.google.com/books?id=fOoFIQOdIhkC&pg=PA549 |archivedate=May 5, 2016 |df=mdy-all }}</ref> Neither method offers protection from sexually transmitted infections.<ref name=Hopkins2010 />

This decision may cause regret in some men and women. Of women aged over 30 who have undergone tubal ligation, about 5% regret their decision, as compared with 20% of women aged under 30.<ref name=Hopkins2010 /> By contrast, less than 5% of men are likely to regret sterilization. Men who are more likely to regret sterilization are younger, have young or no children, or have an unstable marriage.<ref>{{cite book|last=Hatcher|first=Robert|title=Contraceptive technology|year=2008|publisher=Ardent Media|location=New York|isbn=978-1-59708-001-9|page=390|url=https://books.google.com/books?id=txh0LpjjhkoC&pg=PA390|edition=19th|url-status=live|archiveurl=https://web.archive.org/web/20160506181510/https://books.google.com/books?id=txh0LpjjhkoC&pg=PA390|archivedate=May 6, 2016|df=mdy-all}}</ref> In a survey of biological parents, 9% stated they would not have had children if they were able to do it over again.<ref>{{cite book|last=Moore|first=David S.|title=The basic practice of statistics|year=2010|publisher=Freeman|location=New York|isbn=978-1-4292-2426-0|page=25|url=https://books.google.com/books?id=JOMQKI8zj_EC&pg=PR25|edition=5th|url-status=live|archiveurl=https://web.archive.org/web/20160427122639/https://books.google.com/books?id=JOMQKI8zj_EC&pg=PR25|archivedate=April 27, 2016|df=mdy-all}}</ref>

Although sterilization is considered a permanent procedure,<ref name=Deff2011 /> it is possible to attempt a [[tubal reversal]] to reconnect the [[fallopian tubes]] or a [[vasectomy reversal]] to reconnect the [[vasa deferentia]]. In women, the desire for a reversal is often associated with a change in spouse.<ref name=Deff2011 /> Pregnancy success rates after tubal reversal are between 31 and 88 percent, with complications including an increased risk of [[ectopic pregnancy]].<ref name=Deff2011>{{cite journal|last=Deffieux|first=X|last2=Morin Surroca |first2=M |last3=Faivre |first3=E |last4=Pages |first4=F |last5=Fernandez |first5=H |last6=Gervaise |first6=A|title=Tubal anastomosis after tubal sterilization: a review|journal=Archives of Gynecology and Obstetrics|date=May 2011|volume=283|issue=5|pages=1149–58|pmid=21331539|doi=10.1007/s00404-011-1858-1}}</ref> The number of males who request reversal is between 2 and 6 percent.<ref name=Shri2010>{{cite journal|last=Shridharani|first=A|author2=Sandlow, JI|title=Vasectomy reversal versus IVF with sperm retrieval: which is better?|journal=Current Opinion in Urology|date=November 2010|volume=20|issue=6|pages=503–09|pmid=20852426|doi=10.1097/MOU.0b013e32833f1b35}}</ref> Rates of success in fathering another child after reversal are between 38 and 84 percent; with success being lower the longer the time period between the vasectomy and the reversal.<ref name=Shri2010 /> [[Sperm extraction]] followed by [[in vitro fertilization]] may also be an option in men.<ref>{{cite journal|last=Nagler|first=HM|author2=Jung, H|title=Factors predicting successful microsurgical vasectomy reversal|journal=The Urologic Clinics of North America|date=August 2009|volume=36|issue=3|pages=383–90|pmid=19643240|doi=10.1016/j.ucl.2009.05.010}}</ref>

=== Behavioral ===
Behavioral methods involve [[Calendar-based contraceptive methods|regulating the timing]] or method of intercourse to prevent introduction of sperm into the female reproductive tract, either altogether or when an egg may be present.<ref name=Grim2004 /> If used perfectly the first-year failure rate may be around 3.4%, however if used poorly first-year failure rates may approach 85%.<ref>{{cite book|last=Lawrence|first=Ruth|title=Breastfeeding : a guide for the medical professional|year=2010|publisher=Saunders|location=Philadelphia|isbn=978-1-4377-0788-5|page=673|url=https://books.google.com/books?id=jhQ2zHnKEKwC&pg=PA673|edition=7th|df=mdy-all}}</ref>

==== Fertility awareness ====

[[File:Geburtenkontrollkette (cropped).jpg|thumb|A [[CycleBeads]] tool, used for estimating fertility based on days since last menstruation|alt=a birth control chain calendar necklace]]

[[Fertility awareness method]]s involve determining the most fertile days of the [[menstrual cycle]] and avoiding unprotected intercourse.<ref name=Grim2004 /> Techniques for determining fertility include monitoring [[basal body temperature]], [[cervical secretions]], or the day of the cycle.<ref name=Grim2004>{{cite journal|last=Grimes|first=DA|author2=Gallo, MF |author3=Grigorieva, V |author4=Nanda, K |author5= Schulz, KF |title=Fertility awareness-based methods for contraception.|journal=Cochrane Database of Systematic Reviews|date=Oct 18, 2004|issue=4|pages=CD004860|pmid=15495128|doi=10.1002/14651858.CD004860.pub2}}</ref> They have typical first-year failure rates of 24%; perfect use first-year failure rates depend on which method is used and range from 0.4% to 5%.<ref name=Trus2011 /> The evidence on which these estimates are based, however, is poor as the majority of people in trials stop their use early.<ref name=Grim2004 /> Globally, they are used by about 3.6% of couples.<ref name=Sivin2010 /> If based on both basal body temperature and another primary sign, the method is referred to as symptothermal. First-year failure rates of 20% overall and 0.4% for perfect use have been reported in clinical studies of the symptothermal method.<ref name="Jennings 2011">{{cite book|last1=Jennings|first1=Victoria H.|last2=Burke|first2=Anne E.|date=November 1, 2011|chapter=Fertility awareness-based methods|editor1-last=Hatcher|editor1-first=Robert A.|editor2-last=Trussell|editor2-first=James|editor3-last=Nelson|editor3-first=Anita L.|editor4-last=Cates|editor4-first=Willard Jr.|editor5-last=Kowal|editor5-first=Deborah|editor6-last=Policar|editor6-first=Michael S. |title=Contraceptive technology|edition=20th revised|location=New York|publisher=Ardent Media|pages=417–34|isbn=978-1-59708-004-0|issn=0091-9721|oclc=781956734}}</ref><ref name=Trus2011 /> A number of [[fertility tracking]] apps are available, as of 2016, but they are more commonly designed to assist those trying to get pregnant rather than prevent pregnancy.<ref>{{cite journal|last1=Mangone|first1=Emily Rose|last2=Lebrun|first2=Victoria|last3=Muessig|first3=Kathryn E|title=Mobile Phone Apps for the Prevention of Unintended Pregnancy: A Systematic Review and Content Analysis|journal=JMIR mHealth and uHealth|date=19 January 2016|volume=4|issue=1|pages=e6|doi=10.2196/mhealth.4846|pmid=26787311|pmc=4738182}}</ref>

==== Withdrawal ====

The [[withdrawal method]] (also known as coitus interruptus) is the practice of ending intercourse ("pulling out") before ejaculation.<ref name=WHO2009_100>{{cite book|last=Organization|first=World Health|title=Medical eligibility criteria for contraceptive use|year=2009|publisher=Reproductive Health and Research, World Health Organization|location=Geneva|isbn=978-92-4-156388-8|pages=91–100|url=http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf|edition=4th|url-status=live|archiveurl=https://web.archive.org/web/20120709230021/http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf|archivedate=July 9, 2012|df=mdy-all}}</ref> The main risk of the withdrawal method is that the man may not perform the maneuver correctly or in a timely manner.<ref name=WHO2009_100 /> First-year failure rates vary from 4% with perfect usage to 22% with typical usage.<ref name=Trus2011 /> It is not considered birth control by some medical professionals.<ref name=Will2012 />

There is little data regarding the sperm content of [[pre-ejaculatory fluid]].<ref name=Jones2009>{{cite journal|last=Jones|first=RK|author2=Fennell, J |author3=Higgins, JA |author4= Blanchard, K |title=Better than nothing or savvy risk-reduction practice? The importance of withdrawal|journal=Contraception|date=June 2009|volume=79|issue=6|pages=407–10|pmid=19442773|doi=10.1016/j.contraception.2008.12.008}}</ref> While some tentative research did not find sperm,<ref name=Jones2009 /> one trial found sperm present in 10 out of 27 volunteers.<ref>{{cite journal|last=Killick|first=SR|author2=Leary, C |author3=Trussell, J |author4= Guthrie, KA |title=Sperm content of pre-ejaculatory fluid|journal=Human Fertility (Cambridge, England)|date=March 2011|volume=14|issue=1|pages=48–52|pmid=21155689|doi=10.3109/14647273.2010.520798|pmc=3564677}}</ref> The withdrawal method is used as birth control by about 3% of couples.<ref name=Sivin2010>{{cite journal|last=Freundl|first=G|author2=Sivin, I |author3=Batár, I |title=State-of-the-art of non-hormonal methods of contraception: IV. Natural family planning|journal=The European Journal of Contraception & Reproductive Health Care|date=April 2010|volume=15|issue=2|pages=113–23|pmid=20141492|doi=10.3109/13625180903545302}}</ref>

==== Abstinence ====

[[Sexual abstinence]] may be used as a form of birth control, meaning either not engaging in any type of sexual activity, or specifically not engaging in vaginal intercourse, while engaging in other forms of non-vaginal sex.<ref name=PP2009>{{cite web|title=Abstinence|work=Planned Parenthood|year=2009|url=http://www.plannedparenthood.org/health-topics/birth-control/abstinence-4215.htm|accessdate=September 9, 2009|url-status=live|archiveurl=https://web.archive.org/web/20090910053822/http://www.plannedparenthood.org/health-topics/birth-control/abstinence-4215.htm|archivedate=September 10, 2009|df=mdy-all}}</ref><ref>{{cite book |last1=Murthy |first1=Amitasrigowri S |last2=Harwood |first2=Bryna|title=Contraception Update |publisher=Springer |edition=2nd |year=2007 |location=New York |pages=Abstract|doi=10.1007/978-0-387-32328-2_12 |isbn=978-0-387-32327-5}}</ref> Complete sexual abstinence is 100% effective in preventing pregnancy.<ref>{{cite book|last1=Alters|first1=Sandra|last2=Schiff|first2=Wendy|title=Essential Concepts for Healthy Living|date=Oct 5, 2009|publisher=Jones & Bartlett Publishers|isbn=978-0-7637-5641-3|page=116|url=https://books.google.com/books?id=lc-YBRQkldAC|accessdate=30 December 2017}}</ref><ref>{{cite book|last1=Greenberg|first1=Jerrold S.|last2=Bruess|first2=Clint E.|last3=Oswalt|first3=Sara B.|title=Exploring the Dimensions of Human Sexuality|year= 2016|publisher=Jones & Bartlett Publishers|isbn=978-1-4496-9801-0|page=191|url=https://books.google.com/books?id=8iarCwAAQBAJ|accessdate=30 December 2017}}</ref> However, among those who take a [[virginity pledge|pledge to abstain]] from [[premarital sex]], as many as 88% who engage in sex, do so prior to marriage.<ref name=Den2005>{{cite journal |doi=10.1016/j.jadohealth.2005.02.001 |title=The limits of abstinence-only in preventing sexually transmitted infections |year=2005 |last1=Fortenberry |first1=J. Dennis |journal=Journal of Adolescent Health |volume=36 |issue=4 |pages=269–70 |pmid=15780781 |ref=harv}}</ref> The choice to abstain from sex cannot protect against pregnancy as a result of [[rape]], and public health efforts emphasizing abstinence to reduce unwanted pregnancy may have limited effectiveness, especially in [[Developing country|developing countries]] and among [[Disadvantaged|disadvantaged groups]].<ref>{{cite journal | title = Nonconsensual Sex Undermines Sexual Health | journal = Network | year = 2005 | volume = 23 | url = http://www.fhi.org/en/RH/Pubs/Network/v23_4/nt2341.htm | author = Kim Best | issue = 4 | ref = harv | url-status = dead | archiveurl = https://web.archive.org/web/20090218142348/http://www.fhi.org/en/RH/Pubs/Network/v23_4/nt2341.htm | archivedate = February 18, 2009 | df = mdy-all }}</ref><ref>{{cite book|last1=Francis|first1=Leslie|title=The Oxford Handbook of Reproductive Ethics|date=2017|publisher=[[Oxford University Press]]|isbn=978-0-19-998187-8|page=329|url=https://books.google.com/books?id=TS6hDQAAQBAJ|accessdate=30 December 2017}}</ref>

Deliberate [[non-penetrative sex]] without vaginal sex or deliberate [[oral sex]] without vaginal sex are also sometimes considered birth control.<ref name=PP2009/> While this generally avoids pregnancy, pregnancy can still occur with [[intercrural sex]] and other forms of penis-near-vagina sex (genital rubbing, and the penis exiting from [[anal intercourse]]) where sperm can be deposited near the entrance to the vagina and can travel along the vagina's lubricating fluids.<ref>{{cite book|last=Thomas|first=R. Murray|title=Sex and the American teenager seeing through the myths and confronting the issues|year=2009|publisher=Rowman & Littlefield Education|location=Lanham, MD|isbn=978-1-60709-018-2|page=81|url=https://books.google.com/books?id=gM9EFgsJHyoC&pg=PA81}}</ref><ref>{{cite book|last=Edlin|first=Gordon|title=Health & Wellness|year=2012|publisher=Jones & Bartlett Learning|isbn=978-1-4496-3647-0|page=213|url=https://books.google.com/books?id=csGk6j5rlN0C&pg=PA213}}</ref>

[[Abstinence-only sex education]] does not reduce [[teenage pregnancy]].<ref name="pmid22341164" /><ref name=Santelli2017>{{cite journal|last1=Santelli|first1=JS|last2=Kantor|first2=LM|last3=Grilo|first3=SA|last4=Speizer|first4=IS|last5=Lindberg|first5=LD|last6=Heitel|first6=J|last7=Schalet|first7=AT|last8=Lyon|first8=ME|last9=Mason-Jones|first9=AJ|last10=McGovern|first10=T|last11=Heck|first11=CJ|last12=Rogers|first12=J|last13=Ott|first13=MA|title=Abstinence-Only-Until-Marriage: An Updated Review of U.S. Policies and Programs and Their Impact|journal=The Journal of Adolescent Health|date=September 2017|volume=61|issue=3|pages=273–80|doi=10.1016/j.jadohealth.2017.05.031|pmid=28842065 |doi-access=free}}</ref> Teen pregnancy rates and STI rates are generally the same or higher in states where students are given abstinence-only education, as compared with [[comprehensive sex education]].<ref name=Santelli2017/> Some authorities recommend that those using abstinence as a primary method have backup methods available (such as condoms or emergency contraceptive pills).<ref>{{cite book|author=Kowal D|year=2007|chapter=Abstinence and the Range of Sexual Expression|editor=Hatcher, Robert A.|title=Contraceptive Technology|edition=19th rev.|pages=[https://archive.org/details/contraceptivetec00hatc/page/81 81–86]|location=New York|publisher=Ardent Media|isbn=978-0-9664902-0-6|display-editors=etal|chapter-url=https://archive.org/details/contraceptivetec00hatc/page/81}}</ref>

==== Lactation ====

The [[lactational amenorrhea method]] involves the use of a woman's natural [[postpartum infertility]] which occurs after delivery and may be extended by [[breastfeeding]].<ref name=Blackburn2007>{{cite book|last=Blackburn|first=Susan Tucker|title=Maternal, fetal, & neonatal physiology : a clinical perspective|year=2007|publisher=Saunders Elsevier|location=St. Louis, MO|isbn=978-1-4160-2944-1|page=157|url=https://books.google.com/books?id=2y6zOSQcn14C&pg=PA157|edition=3rd|url-status=live|archiveurl=https://web.archive.org/web/20160512050446/https://books.google.com/books?id=2y6zOSQcn14C&pg=PA157|archivedate=May 12, 2016|df=mdy-all}}</ref> This usually requires the presence of no [[menstruation|periods]], exclusively breastfeeding the infant, and a child younger than six months.<ref name=Blenning2005>{{cite journal|last=Blenning|first=CE|author2=Paladine, H|title=An approach to the postpartum office visit|journal=American Family Physician|date=Dec 15, 2005|volume=72|issue=12|pages=2491–96|pmid=16370405}}</ref> The [[World Health Organization]] states that if breastfeeding is the infant's only source of nutrition, the failure rate is 2% in the six months following delivery.<ref>{{cite web|title=WHO 10 facts on breastfeeding|work=World Health Organization|date=April 2005|url=http://www.who.int/features/factfiles/breastfeeding/facts/en/index2.html|url-status=live|archiveurl=https://web.archive.org/web/20130623231136/http://www.who.int/features/factfiles/breastfeeding/facts/en/index2.html|archivedate=June 23, 2013|df=mdy-all}}</ref> Six uncontrolled studies of lactational amenorrhea method users found failure rates at 6 months postpartum between 0% and 7.5%.<ref name=Vander2008>{{cite journal|last1=Van der Wijden|first1=Carla|last2=Brown|first2=Julie|last3=Kleijnen|first3=Jos|date=October 8, 2008|title=Lactational amenorrhea for family planning|journal=Cochrane Database of Systematic Reviews|issue=4|page=CD001329|doi=10.1002/14651858.CD001329|pmid=14583931|editor1-last=Van Der Wijden|editor1-first=Carla}}</ref>{{Update inline|reason=Updated version https://www.ncbi.nlm.nih.gov/pubmed/26457821|date=February 2017}} Failure rates increase to 4–7% at one year and 13% at two years.<ref name=Fritz2012>{{cite book|last=Fritz|first=Marc|title=Clinical Gynecologic Endocrinology and Infertility|year=2012|isbn=978-1-4511-4847-3|pages=1007–08|url=https://books.google.com/books?id=KZLubBxJEwEC&pg=PA1007|url-status=live|archiveurl=https://web.archive.org/web/20160603173728/https://books.google.com/books?id=KZLubBxJEwEC&pg=PA1007|archivedate=June 3, 2016|df=mdy-all}}</ref> Feeding formula, pumping instead of nursing, the use of a [[pacifier]], and feeding solids all increase its failure rate.<ref>{{cite book|last=Swisher|first=Judith Lauwers, Anna|title=Counseling the nursing mother a lactation consultant's guide|publisher=Jones & Bartlett Learning|location=Sudbury, MA|isbn=978-1-4496-1948-0|pages=465–66|url=https://books.google.com/books?id=2X0_Takcr_wC&pg=PA465|edition=5th|url-status=live|archiveurl=https://web.archive.org/web/20160616223833/https://books.google.com/books?id=2X0_Takcr_wC&pg=PA465|archivedate=June 16, 2016|df=mdy-all|date=2010-10-25}}</ref> In those who are exclusively breastfeeding, about 10% begin having periods before three months and 20% before six months.<ref name=Fritz2012 /> In those who are not breastfeeding, fertility may return four weeks after delivery.<ref name=Fritz2012 />

=== Emergency ===
[[File:Emergency contraceptive (cropped).jpg|thumb|A split dose of two [[emergency contraceptive]] pills|alt=emergency contraceptive pills]]

[[Emergency contraceptive]] methods are medications (sometimes misleadingly referred to as "morning-after pills")<ref>{{cite web|author1=Office of Population Research|author2=Association of Reproductive Health Professionals|date=July 31, 2013|title=What is the difference between emergency contraception, the 'morning after pill', and the 'day after pill'?|location=Princeton|publisher=Princeton University|url=http://ec.princeton.edu/questions/morningafter.html|accessdate=September 7, 2013|url-status=live|archiveurl=https://web.archive.org/web/20130923062617/http://ec.princeton.edu/questions/morningafter.html|archivedate=September 23, 2013|df=mdy-all}}</ref> or devices used after unprotected sexual intercourse with the hope of preventing pregnancy. Emergency contraceptives are often given to victims of [[Rape]]<ref name=Gizzo2012 /> They work primarily by preventing ovulation or fertilization.<ref name=Hopkins2010 /><ref name=Leu2010>{{cite journal|last1=Leung|first1=Vivian W Y|last2=Levine|first2=Marc|last3=Soon|first3=Judith A|title=Mechanisms of Action of Hormonal Emergency Contraceptives|journal=Pharmacotherapy|date=February 2010|volume=30|issue=2|pages=158–68|doi=10.1592/phco.30.2.158|quote=The evidence strongly supports disruption of ovulation as a mechanism of action. The data suggest that emergency contraceptives are unlikely to act by interfering with implantation|pmid=20099990}}</ref> They are unlikely to affect implantation, but this has not been completely excluded.<ref name=Leu2010/> A number of options exist, including [[Yuzpe regimen|high dose birth control pills]], [[levonorgestrel]], [[mifepristone]], [[ulipristal]] and IUDs.<ref name=Shen2019>{{Cite journal|last=Shen|first=Jie|last2=Che|first2=Yan|last3=Showell|first3=Emily|last4=Chen|first4=Ke|last5=Cheng|first5=Linan|date=2019-01-20|editor-last=Cochrane Fertility Regulation Group|title=Interventions for emergency contraception|journal=Cochrane Database of Systematic Reviews|language=en|doi=10.1002/14651858.CD001324.pub6|pmid=30661244|volume=1|page=CD001324|pmc=7055045}}</ref> Providing emergency contraceptive pills to women in advance does not affect rates of sexually transmitted infections, condom use, pregnancy rates, or sexual risk-taking behavior.<ref name="pmid17894132">{{cite journal |author=Kripke C |title=Advance provision for emergency oral contraception |journal=Am Fam Physician |volume=76 |issue=5 |page=654 |date=September 2007 |pmid=17894132 |doi= |url=}}</ref><ref name="pmid21923590">{{cite journal |vauthors=Shrader SP, Hall LN, Ragucci KR, Rafie S |title=Updates in hormonal emergency contraception |journal=Pharmacotherapy |volume=31 |issue=9 |pages=887–95 |date=September 2011 |pmid=21923590 |doi=10.1592/phco.31.9.887 |url=}}</ref> All methods have minimal side effects.<ref name=Shen2019 />

[[Levonorgestrel]] pills, when used within 3&nbsp;days, decrease the chance of pregnancy after a single episode of unprotected sex or condom failure by 70% (resulting in a pregnancy rate of 2.2%).<ref name=Gizzo2012 /> [[Ulipristal]], when used within 5&nbsp;days, decreases the chance of pregnancy by about 85% (pregnancy rate 1.4%) and is more effective than levonorgestrel.<ref name=Gizzo2012 /><ref name=Shen2019 /><ref>{{cite journal|last=Richardson|first=AR|author2=Maltz, FN|title=Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception|journal=Clinical Therapeutics|date=January 2012|volume=34|issue=1|pages=24–36|pmid=22154199|doi=10.1016/j.clinthera.2011.11.012}}</ref> [[Mifepristone]] is also more effective than levonorgestrel, while copper IUDs are the most effective method.<ref name=Shen2019 /> IUDs can be inserted up to five&nbsp;days after intercourse and prevent about 99% of pregnancies after an episode of unprotected sex (pregnancy rate of 0.1 to 0.2%).<ref name=Hopkins2010 /><ref>{{cite web|title=Update on Emergency Contraception|url=http://www.arhp.org/Publications-and-Resources/Clinical-Proceedings/EC/Effectiveness|publisher=Association of Reproductive Health Professionals|accessdate=May 20, 2013|date=March 2011|url-status=live|archiveurl=https://web.archive.org/web/20130511124153/http://www.arhp.org/Publications-and-Resources/Clinical-Proceedings/EC/Effectiveness|archivedate=May 11, 2013|df=mdy-all}}</ref> This makes them the most effective form of emergency contraceptive.<ref name=Cleland2012>{{cite journal |vauthors=Cleland K, Zhu H, Goldstruck N, Cheng L, Trussel T |year=2012 |title=The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience |journal=Human Reproduction |volume=27 |issue=7 |pages=1994–2000 |doi=10.1093/humrep/des140 |pmid=22570193 |ref=harv|pmc=3619968 }}</ref> In those who are [[overweight]] or [[obese]], levonorgestrel is less effective and an IUD or ulipristal is recommended.<ref>{{cite journal|last=Glasier|first=A|author2=Cameron, ST |author3=Blithe, D |author4=Scherrer, B |author5=Mathe, H |author6=Levy, D |author7=Gainer, E |author8= Ulmann, A |title=Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel|journal=Contraception|date=Oct 2011|volume=84|issue=4|pages=363–67|pmid=21920190|doi=10.1016/j.contraception.2011.02.009}}</ref>

=== Dual protection ===

Dual protection is the use of methods that prevent both [[sexually transmitted infection]]s and pregnancy.<ref>{{cite journal |title=Dual protection against unwanted pregnancy and HIV / STDs |journal=Sex Health Exch |issue=3 |page=8 |year=1998 |pmid=12294688 |doi= |url=}}</ref> This can be with condoms either alone or along with another birth control method or by the avoidance of [[sexual intercourse|penetrative sex]].<ref name=Cates2002>{{cite journal|author1=Cates, W.|author2=Steiner, M.J.|year=2002|title=Dual Protection Against Unintended Pregnancy and Sexually Transmitted Infections: What Is the Best Contraceptive Approach?|journal=Sexually Transmitted Diseases|volume=29|issue=3|pages=168–74|doi=10.1097/00007435-200203000-00007|pmid=11875378|ref=harv|df=mdy-all}}</ref><ref>{{cite web|publisher=International Planned Parenthood Federation|date=May 2000|title=Statement on Dual Protection against Unwanted Pregnancy and Sexually Transmitted Infections, including HIV|url=http://www.popline.org/node/172494|url-status=live|archiveurl=https://web.archive.org/web/20160410055528/http://www.popline.org/node/172494|archivedate=April 10, 2016|df=mdy-all}}</ref>

If pregnancy is a high concern, using two methods at the same time is reasonable.<ref name="Cates2002" /> For example, two forms of birth control are recommended in those taking the anti-[[acne]] drug [[isotretinoin]] or [[anti-epileptic drugs]] like [[carbamazepine]], due to the high risk of [[birth defect]]s if taken during pregnancy.<ref name="Gupta2011">{{cite book|last=Gupta|first=Ramesh C.|title=Reproductive and Developmental Toxicology|url=https://books.google.com/books?id=jGHRR32wz5MC|year= 2011|publisher=Academic Press|isbn=978-0-12-382032-7|page=105|url-status=live|archiveurl=https://web.archive.org/web/20160516180230/https://books.google.com/books?id=jGHRR32wz5MC|archivedate=May 16, 2016|df=mdy-all}}</ref><ref>{{Cite journal|last=Bhakta|first=J|last2=Bainbridge|first2=J|last3=Borgelt|first3=L|date=Nov 2015|title=Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy|pmid=26460786|journal=Epilepsy Behav|volume=52|issue=Pt A|pages=212–17|doi=10.1016/j.yebeh.2015.08.004}}</ref>

== References ==
{{Reflist}}
